Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > Dr. Anke M. Schulte

<< Previous

Bullboard Posts

Next >>

Comment by Charly50on Jul 19, 2021 8:12am

219 Views

Post# 33568076

RE:RE:RE:Dr. Anke M. Schulte

Philip Tolekis replied:

Q: has the relationship with Anke Schulte changed with her movement to Bayer?

A: I have known that Anke is moving from Sanofi through communication with her. I think this is a very good move as Bayer is embarking on a cell therapy program which could be beneficial for Sernova.

<< Previous

Bullboard Posts

Next >>

Advancing flagship Ishkõday Gold Project in Ontario